DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Higuchi K, Tanabe S, Shimada K, Hosaka H, Sasaki E, Nakayama N. et al.
Biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer: A randomised phase III trial (TCOG GI-0801/BIRIP trial).
Eur J Cancer 2014;
50: 1437-45
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.